Skip to main content
. 2022 Apr;18(4 Suppl 1):2–3.

Figure 1.

Figure 1.

Symptomatic response in patients with moderately to severely active ulcerative colitis during induction treatment with ozanimod in the phase 3 True North trial. Adapted from Siegmund B et al. ECCO abstract DOP43. J Crohns Colitis. 2022;16(suppl 1).2